4.4 Review

Chemically-modified HA for therapy and regenerative medicine

Journal

CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Volume 9, Issue 4, Pages 242-245

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920108785161523

Keywords

cross-linking; gels; scaffolds; biomaterials

Funding

  1. NIH
  2. NSF
  3. Center for Biotechnology at the University at Stony Brook
  4. MedChem Products, Inc.
  5. Anika Therapeutics, Inc.
  6. Clear Solutions Biotech, Inc.
  7. Sentrx Surgical, Inc.
  8. University of Utah
  9. Utah Centers of Excellence Program

Ask authors/readers for more resources

Hyaluronan (HA) is a very useful polymer, but its properties sometimes need to be altered or enhanced by chemical modification for biomedical applications. A wide variety of HA derivatives are currently used for eye surgery, joint viscoelastic supplementation, and anti-adhesion films. The future promises to deliver new classes of HA-based reagents as well as new polymers that can be used in situ with living cells or within the body.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available